AstraZeneca's hopes for baxdrostat are high, as in early 2023 it acquired the drug by purchasing its developer -- biotech ...
Assertio (ASRT) beats Q3 revenue estimates with strong Rolvedon demand and updates its 2024 forecasts. Read more here.
Scholar Rock Holding Company ( SRRK) is a Boston-based, clinical-stage biotech that was founded in 2012, focusing on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback